Viewing Study NCT03465592


Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2026-01-05 @ 2:55 AM
Study NCT ID: NCT03465592
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2018-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module